Flixotide
Pajjiż: New Zealand
Lingwa: Ingliż
Sors: Medsafe (Medicines Safety Authority)
Xi dokumenti għal dan il-prodott mhumiex disponibbli bħalissa, tista 'tibgħat talba lis-servizz tal-konsumatur tagħna u aħna ninnotifikawkom malli nkunu nistgħu niksbuhom.
Ibgħat talba.
Ibgħat talba.
Ingredjent attiv:
Fluticasone propionate 125ug;
Disponibbli minn:
GlaxoSmithKline NZ Limited
INN (Isem Internazzjonali):
Fluticasone propionate 125 µg
Dożaġġ:
125 mcg/dose
Għamla farmaċewtika:
Aerosol inhaler, metered dose
Kompożizzjoni:
Active: Fluticasone propionate 125ug Excipient: Dichlorodifluoromethane Lecithin Trichlorofluoromethane
Unitajiet fil-pakkett:
Inhaler, metered, 60 dose units
Klassi:
Prescription
Tip ta 'preskrizzjoni:
Prescription
Manifatturat minn:
Glaxo Wellcome Manufacturing Pte Ltd
Sommarju tal-prodott:
Package - Contents - Shelf Life: Inhaler, metered, - 60 dose units - 24 months from date of manufacture stored at or below 30°C - Inhaler, metered, 1x120 doses - 120 dose units - 24 months from date of manufacture stored at or below 30°C
Data ta 'l-awtorizzazzjoni:
1992-06-08
